Sathe P, Ramdasi G, Giammatteo K, Beauzile H, Wang S, Zhang H
Pharmacol Res Perspect. 2023; 11(5):e01144.
PMID: 37837184
PMC: 10576165.
DOI: 10.1002/prp2.1144.
Gwynne W, Shakeel M, Girgis-Gabardo A, Hassell J
Molecules. 2021; 26(11).
PMID: 34073226
PMC: 8198186.
DOI: 10.3390/molecules26113171.
Barnes N, Ahern G, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S
Pharmacol Rev. 2020; 73(1):310-520.
PMID: 33370241
PMC: 7770494.
DOI: 10.1124/pr.118.015552.
Gwynne W, Shakeel M, Girgis-Gabardo A, Kim K, Ford E, Dvorkin-Gheva A
BMC Cancer. 2020; 20(1):724.
PMID: 32758183
PMC: 7404930.
DOI: 10.1186/s12885-020-07193-6.
Tortosa V, Pietropaolo V, Brandi V, Macari G, Pasquadibisceglie A, Polticelli F
Molecules. 2020; 25(9).
PMID: 32397407
PMC: 7248939.
DOI: 10.3390/molecules25092229.
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.
Kuypers K, Ng L, Erritzoe D, Knudsen G, Nichols C, Nichols D
J Psychopharmacol. 2019; 33(9):1039-1057.
PMID: 31303095
PMC: 6732823.
DOI: 10.1177/0269881119857204.
Ligand-directed serotonin 5-HT receptor desensitization and sensitization.
Felsing D, Canal C, Booth R
Eur J Pharmacol. 2019; 848:131-139.
PMID: 30689993
PMC: 6767919.
DOI: 10.1016/j.ejphar.2019.01.037.
Biophysical validation of serotonin 5-HT2A and 5-HT2C receptor interaction.
Felsing D, Anastasio N, Miszkiel J, Gilbertson S, Allen J, Cunningham K
PLoS One. 2018; 13(8):e0203137.
PMID: 30157263
PMC: 6114921.
DOI: 10.1371/journal.pone.0203137.
5-HT serotonin receptors modulate mitogenic signaling and impact tumor cell viability.
Ballou Y, Rivas A, Belmont A, Patel L, Amaya C, Lipson S
Mol Clin Oncol. 2018; 9(3):243-254.
PMID: 30155245
PMC: 6109681.
DOI: 10.3892/mco.2018.1681.
5-HT3 Receptors: A Potential Therapeutic Target for Epilepsy.
Zhao H, Lin Y, Chen S, Li X, Huo H
Curr Neuropharmacol. 2017; 16(1):29-36.
PMID: 28486926
PMC: 5771379.
DOI: 10.2174/1570159X15666170508170412.
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.
Gwynne W, Hallett R, Girgis-Gabardo A, Bojovic B, Dvorkin-Gheva A, Aarts C
Oncotarget. 2017; 8(19):32101-32116.
PMID: 28404880
PMC: 5458271.
DOI: 10.18632/oncotarget.16646.
Fluoxetine effects on periodontogenesis: histomorphometrical and immunohistochemical analyses in rats.
Regueira L, Leite de Marcelos P, Santiago-Jaegger I, Perez D, Evencio Neto J, Baratella-Evencio L
J Appl Oral Sci. 2017; 25(2):159-167.
PMID: 28403356
PMC: 5393536.
DOI: 10.1590/1678-77572015-0564.
A short history of the 5-HT receptor: from the choroid plexus to depression, obesity and addiction treatment.
Palacios J, Pazos A, Hoyer D
Psychopharmacology (Berl). 2017; 234(9-10):1395-1418.
PMID: 28265714
DOI: 10.1007/s00213-017-4545-5.
Glucagon-Like Peptide 1 and Its Analogs Act in the Dorsal Raphe and Modulate Central Serotonin to Reduce Appetite and Body Weight.
Anderberg R, Richard J, Eerola K, Lopez-Ferreras L, Banke E, Hansson C
Diabetes. 2017; 66(4):1062-1073.
PMID: 28057699
PMC: 6237271.
DOI: 10.2337/db16-0755.
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.
Hallett R, Girgis-Gabardo A, Gwynne W, Giacomelli A, Bisson J, Jensen J
Oncotarget. 2016; 7(33):53137-53152.
PMID: 27447971
PMC: 5288174.
DOI: 10.18632/oncotarget.10614.
Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice.
Gurel V, Lins J, Lambert K, Lazauski J, Spaulding J, McMichael J
Dose Response. 2016; 13(4):1559325815616351.
PMID: 26740813
PMC: 4679190.
DOI: 10.1177/1559325815616351.
Genomic structure and expression of the human serotonin 2A receptor gene (HTR2A) locus: identification of novel HTR2A and antisense (HTR2A-AS1) exons.
Ruble C, Smith R, Calley J, Munsie L, Airey D, Gao Y
BMC Genet. 2016; 17:16.
PMID: 26738766
PMC: 4702415.
DOI: 10.1186/s12863-015-0325-6.
The role of serotonin 5-HT2A receptors in memory and cognition.
Zhang G, Stackman Jr R
Front Pharmacol. 2015; 6:225.
PMID: 26500553
PMC: 4594018.
DOI: 10.3389/fphar.2015.00225.
The serotonin-2 receptor modulator, (-)-trans-PAT, decreases voluntary ethanol consumption in rats.
Kasper J, Tikamdas R, Kim M, MacFadyen K, Aramini R, Ladd J
Eur J Pharmacol. 2013; 718(1-3):98-104.
PMID: 24041931
PMC: 3833445.
DOI: 10.1016/j.ejphar.2013.09.008.
Serotonin receptors in hippocampus.
Berumen L, Rodriguez A, Miledi R, Garcia-Alcocer G
ScientificWorldJournal. 2012; 2012:823493.
PMID: 22629209
PMC: 3353568.
DOI: 10.1100/2012/823493.